Cooley Advises Ambit on its Initial Public Offering

San Diego, Calif. – May 21, 2013 – Cooley LLP announced today that it represented Ambit Biosciences on its initial public offering. Ambit, a San Diego-based biopharmaceutical company focused on the treatment of unmet medical needs in oncology, autoimmune and inflammatory diseases, now trades on the NASDAQ Global Stock Market under the symbol "AMBI."

About Cooley LLP

Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small clients with big ideas to international clients with diverse legal needs, Cooley has the breadth of legal resources to enable clients of all shapes and sizes to seize opportunities in today's global marketplace. We represent clients across a broad array of dynamic industry sectors, including the financial sector, law firms, media, technology, life sciences, health care, venture capital, clean energy, real estate and retail.

Based on the American Lawyer's 2012 Corporate Scorecard, Cooley served as issuer counsel on 40 total US equity offerings, ranking as the most active law firm advising issuers in the country. Cooley was also the third most active law firm advising underwriters on US IPOs.

Cooley has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC and Shanghai, China.

Related Contacts
Susan Cooper Philpot Partner, San Francisco
Bill Morrow Retired Partner, San Diego
Tom Coll Partner, San Diego
Ken Rollins Partner, San Diego
James Pennington Special Counsel, San Diego
Megan Arthur Schilling Partner, San Diego
Natasha Leskovsek Partner, Washington, DC
Karen Anderson Partner, San Diego
Terren O'Connor Associate, San Diego
Related Practices & Industries

Compensation & Benefits Capital Markets Tax